-
-
CD4+ t cells were obtained from HIV-negative donors and HIV-positive patients receiving HAART with suppressed viremia. Using a single-cycle replication system and an X4 pseudovirus used to infect cells, minocycline, at concentrations from 0-50 ug/mL, demonstrated a dose-dependent reduction in the percentage of infected cells.
-
Twenty-one patients with HIV-1/AIDS, seven patients with hiv-2/aids, 43 patients with HIV-1 chronic infection, and 66 patients with HIV-2 chronic infection in Guinea-Bissau were studied along with 66 HIV-negative policemen.
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
These authors assessed the benefits of antiviral therapy of the index flu patient on reduced viral shedding and prevention of secondary household cases who did not receive chemoprophylaxis.
-
Piperacillin/Tazobactam (P/T) offers one of the broadest antimicrobial spectrums, and is equipped with an effective mechanism to maintain its potency in the presence of beta-lactamases.
-
The prostate cancer prevention trial did not ignite advocacy among clinicians for chemoprevention of prostate cancer (PCA).
-
The more fruits and vegetables you eat, the lower your overall cancer risk.
-
The ECG shown above was obtained from a 54-year-old man with atypical chest pain. Is there cause for concern?
-
A rifamycin antibacterial agent has been approved for treating patients with hepatic encephalopathy (HE).